Health
Expert panel provides guidance for optimized design of early drug trials for Alzheimer’s, related dementias – News-Medical.Net
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best…
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology®, the medical journal of the American Academy of Neurology (“Value-Generating Exploratory Trials in Neurodegenerative Dementias”).
…
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
General20 hours agoOne person dead after house fire in Melbourne’s south-east
-
Noosa News16 hours agoYou’ll Be Waiting a Bit Longer for the Next Two ‘Avengers’ Films, with ‘Doomsday’ and ‘Secret Wars’ Both Pushing Back Their Release Dates